Please Sign In or Register to access all E-Script Features
Patient : 0.00
Retainer : 0.00 (Applied in checkout)
Practitioner : 0.00
Therapeutic Actions1.Has an anti-inflammatory effect, dissolves necrotic tissue (blood clots), arterial plaques, thin lung secretions, may reduce fibrinolytic activity2.Treats chronic lung, ear, nose and throat disorders3.Sinusitis, sprains, edema, postoperative inflammation, carpal tunnel syndrome, breast engorgement, (fibrocystic breast disease) venous inflammatory disease, asthma, cardiovascular disease, inflammatory pain conditions, leg ulcers, chronic headaches4.Through proteolytic activity digest scar tissue and speeds healing response
Formula
Serramend contains serratiopeptidase also known as serrapeptase; a naturally occurring proteolytic enzyme that has been used clinically in Europe and Asia for over thirty years. It has been well tested and shown efficacy for many conditions including traumatic injury, postoperative inflammation, ear, nose and throat conditions, carpal tunnel syndrome, fibrocystic breast disease, and venous disease. It has also been promoted for the treatment of inflammatory pain conditions and cardiovascular diseases.
In patients with chronic airway disease treatment with 30 mg. per day of serrapeptase for four weeks resulted in changes in sputum. Coughing and expectoration frequency were significantly decreased. Serrapeptase has also been used to treat chronic sinusitis at a dosage of 30 mg. per day for four weeks leading to reduced sputum viscosity and improved quality of life. In several treatment centers with 193 patients, suffering from inflammatory ear, nose and throat conditions, treatment was compared with a placebo for seven to eight days. Compared with placebo, serrapeptase produced a more rapid response, researchers concluded that the enzyme treatment produced antiedemic, and fibrinolytic activity. The same dosage was used in a 174 patient study of clients undergoing surgery to correct buccal membrane swelling. Patients in the treatment group demonstrated significantly less swelling compared with the placebo group.
Another surgical study showed a reduction in the amount of postoperative swelling. Patients who received serrapeptase experience a 50 percent decrease in swelling on the third day following ankle surgery. Patients treated with standard measures (leg elevation, bed rest, ice) had no reduction in swelling. In treating carpal tunnel syndrome, 10 mg. twice daily for six weeks, led to significant clinical improvement in 65 percent of the patients. Results were confirmed via nerve-conduction studies. In a group of seventy women with cystic breast disease, 85.7 percent of the patients taking the enzyme had moderate to marked improvement. Serrapeptase has also been clinically studied and shown effective for the treatment of chronic bronchitis and venous inflammatory disease, and improving the effects of the antibiotics ofloxacin, cephalexin, and cefotiam.
Serratiopeptidase 10mg of enteric coated serratiopeptidase per capsule (not less than 2000 units per mg) derived from L Serratia E15
Therapeutic Actions1.Has an anti-inflammatory effect, dissolves necrotic tis...
Serratiopeptidase 10mg of enteric coated...